WHEN IS A CANCER-TREATMENT WORTHWHILE

被引:23
作者
TANNOCK, IF
BOYER, M
机构
关键词
D O I
10.1056/NEJM199010043231410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:989 / 990
页数:2
相关论文
共 11 条
[1]   RATIONING MEDICAL PROGRESS - THE WAY TO AFFORDABLE HEALTH-CARE [J].
CALLAHAN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (25) :1810-1813
[2]   A RANDOMIZED TRIAL OF INDUCTION CHEMOTHERAPY PLUS HIGH-DOSE RADIATION VERSUS RADIATION ALONE IN STAGE-III NON-SMALL-CELL LUNG-CANCER [J].
DILLMAN, RO ;
SEAGREN, SL ;
PROPERT, KJ ;
GUERRA, J ;
EATON, WL ;
PERRY, MC ;
CAREY, RW ;
FREI, EF ;
GREEN, MR .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :940-945
[3]   COSTS AND BENEFITS OF ADJUVANT THERAPY IN BREAST-CANCER - A QUALITY-ADJUSTED SURVIVAL ANALYSIS [J].
GOLDHIRSCH, A ;
GELBER, RD ;
SIMES, RJ ;
GLASZIOU, P ;
COATES, AS .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :36-44
[4]   COUNTING THE COSTS OF CHEMOTHERAPY IN A NATIONAL-CANCER-INSTITUTE-OF-CANADA RANDOMIZED TRIAL IN NONSMALL-CELL LUNG-CANCER [J].
JAAKKIMAINEN, L ;
GOODWIN, PJ ;
PATER, J ;
WARDE, P ;
MURRAY, N ;
RAPP, E .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1301-1309
[5]   THE USE OF EXPERT SURROGATES TO EVALUATE CLINICAL-TRIALS IN NON-SMALL CELL LUNG-CANCER [J].
MACKILLOP, WJ ;
WARD, GK ;
OSULLIVAN, B .
BRITISH JOURNAL OF CANCER, 1986, 54 (04) :661-667
[6]   FALLACY OF 5-YEAR SURVIVAL IN LUNG-CANCER [J].
MCNEIL, BJ ;
WEICHSELBAUM, R ;
PAUKER, SG .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (25) :1397-1401
[7]   ELICITING PREFERENCES FOR ALTERNATIVE DRUG THERAPIES IN ONCOLOGY - INFLUENCE OF TREATMENT OUTCOME DESCRIPTION, ELICITATION TECHNIQUE AND TREATMENT EXPERIENCE ON PREFERENCES [J].
OCONNOR, AMC ;
BOYD, NF ;
WARDE, P ;
STOLBACH, L ;
TILL, JE .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (08) :811-818
[9]  
SIMES RJ, 1989, P AN M AM SOC CLIN, V8, P52
[10]   TREATING THE PATIENT, NOT JUST THE CANCER [J].
TANNOCK, IF .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (24) :1534-1535